Purification and characterization of a human leukemia cell-derived immunosuppressive factor

M Abolhassani1, J W Chiao

  • 1Department of Medicine, New York Medical College, Valhalla 10595.

Preparative Biochemistry
|January 1, 1991
PubMed

Insights

Researchers purified a human leukemia cell-derived suppressor factor (LDSF) that inhibits normal lymphocyte proliferation and activation. This protein, isolated from HL-60 cells, is a stable 66 kDa molecule.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Leukemia cells can produce factors that suppress normal immune responses.
  • Understanding these factors is crucial for developing targeted therapies.

Purpose of the Study:

  • To purify and characterize a human leukemia cell-derived suppressor factor (LDSF).
  • To investigate the effects of LDSF on normal human lymphocyte proliferation and activation.

Main Methods:

  • Purification of LDSF from HL-60 cell culture supernatant using ion-exchange chromatography, gel filtration, and electrophoresis.
  • Assessment of LDSF's effect on lymphocyte proliferation and activation in vitro.
  • Determination of LDSF's molecular mass, stability, and effects on specific receptor expression.

Main Results:

  • A protein factor (LDSF) suppressing lymphocyte proliferation and activation was isolated.
  • Purified LDSF is a single-chain protein with a molecular mass of 66,000 daltons.
  • LDSF is heat-stable and does not induce lymphocyte cytolysis or affect IL-2/transferrin receptor expression.

Conclusions:

  • Leukemia cells constitutively produce a potent immunosuppressive factor.
  • The purified LDSF represents a potential target for modulating immune responses in leukemia.

Related Concept Videos